Lidia Gurba-Bryśkiewicz

Do Small Molecules Activate the TrkB Receptor in the Same Manner as BDNF? Limitations of Published TrkB Low Molecular Agonists and Screening for Novel TrkB Orthosteric Agonists

M. Nowotny, M. Wieczorek, Izabela Rutkowska-Wlodarczyk, 2021, Pharmaceuticals.

Design, Synthesis, and Development of pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part I—Indole Derivatives

F. Stefaniak, K. Dzwonek, M. Wieczorek, 2022, Pharmaceuticals.

Design, Synthesis, and Development of Pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part II—Benzimidazole Derivatives

M. Wieczorek, Beata M Zygmunt, U. Kędzierska, 2022, Pharmaceuticals.

The design of experiments (DoE) in optimization of an aerobic flow Pd-catalyzed oxidation of alcohol towards an important aldehyde precursor in the synthesis of phosphatidylinositide 3-kinase inhibitor (CPL302415)

M. Wieczorek, Anna M. Maj, W. Maruszak, 2022, RSC Advances.

Results from Genetic Studies in Patients Affected with Craniosynostosis: Clinical and Molecular Aspects

A. Szczepankiewicz, A. Materna-Kiryluk, D. Larysz, 2022, Frontiers in Molecular Biosciences.

Implementation of QbD Approach to the Development of Chromatographic Methods for the Determination of Complete Impurity Profile of Substance on the Preclinical and Clinical Step of Drug Discovery Studies

M. Wieczorek, W. Maruszak, M. Mroczkiewicz, 2022, International journal of molecular sciences.

Discovery and development of CPL207280 as new GPR40/FFA1 agonist.

M. Wieczorek, M. Matłoka, Urszula Dawid, 2021, European journal of medicinal chemistry.

Tuning the Biological Activity of PI3Kδ Inhibitor by the Introduction of a Fluorine Atom Using the Computational Workflow

Rafał Kurczab, M. Wieczorek, W. Maruszak, 2023, Molecules.